LBF20207OX01: Difference between revisions

No edit summary
 
No edit summary
 
(16 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}


Line 4: Line 6:
|LipidBank=DFA8155
|LipidBank=DFA8155
|LipidMaps=LMFA01060073
|LipidMaps=LMFA01060073
|SysName=15-oxo-11Z,13E-eicosadienoic acid
|SysName=15-Oxo- (cis-11,trans-13) -eicosadienoic acid
|UV Spectra=<FONT FACE="Symbol">l</FONT>max: 279nm <FONT FACE="Symbol">e</FONT>: 23,000
|Common Name=&&15-Oxo-(11Z,13E) -eicosadienoic acid&&
|UV Spectra= lambda max: 279nm epsilon : 23,000
|Source=
|Chemical Synthesis=
|Metabolism=
|Symbol=15-OxoEDE/15-KEDE
|Biological Activity=15-OxoEDE is produced by the oxidation of 15-HEDE. Some other oxo-eicosanoids have been shown to be biosynthesized and to have potent inflammatory activity [[Reference:Powell_WS:Gravelle_F:Gravel_S:,J. Biol. Chem.,1992,267,19233|{{RelationTable/GetFirstAuthor|Reference:Powell_WS:Gravelle_F:Gravel_S:,J. Biol. Chem.,1992,267,19233}}]].
}}
}}
{{Lipid/Footer}}

Latest revision as of 07:30, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



15-Oxo-(11Z,13E) -eicosadienoic acid
LBF20207OX01.png
Structural Information
15-Oxo- (cis-11,trans-13) -eicosadienoic acid
  • 15-Oxo-(11Z,13E) -eicosadienoic acid
15-OxoEDE/15-KEDE
Formula C20H34O3
Exact Mass 322.25079495399996
Average Mass 322.48216
SMILES C(CCC(C=CC=CCCCCCCCCCC(O)=O)=O)CC
Physicochemical Information
15-OxoEDE is produced by the oxidation of 15-HEDE. Some other oxo-eicosanoids have been shown to be biosynthesized and to have potent inflammatory activity Powell_WS et al..
Spectral Information
Mass Spectra
UV Spectra λ max: 279nm ε : 23,000
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207OX01 See above. Powell_WS et al. 1992